project id: TCGA-ACC; case submitter id: TCGA-OR-A5LG; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.84; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.29; rna integrity number: 8.3; age at index: 46; days to birth: -16875; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1962; age at diagnosis: 16875; ajcc clinical m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage III; ajcc pathologic t: T3; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1589.0; icd 10 code: C74.0; last known disease status: not reported; morphology: 8370/3; primary diagnosis: Adrenal cortical carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cortex of adrenal gland; synchronous malignancy: No; tissue or organ of origin: Cortex of adrenal gland; tumor grade: Not Reported; year of diagnosis: 2008; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 1667; initial weight: 180.0; sample id: d2d69df9-e7eb-4f4c-84ce-cdf150be8503; sample submitter id: TCGA-OR-A5LG-01A; portion id: c4645b98-6b59-41d3-b458-502b2fff63d6; portion submitter id: TCGA-OR-A5LG-01A-11; slide id: 5bcf6123-3767-4354-bd50-10a051284c3d; slide submitter id: TCGA-OR-A5LG-01A-01-TSA; percent lymphocyte infiltration: 20.0; percent monocyte infiltration: 20.0; percent necrosis: 5.0; percent neutrophil infiltration: 40.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 95.0; percent tumor nuclei: 95.0; section location: TOP;